Interpretable Policies and the Price of Interpretability in Hypertension Treatment Planning

References

• Arias E (2019) United States life tables, 2017. National Vital Statist. Rep. 68(7):1–66.Google Scholar
• Ayer T, Zhang C, Bonifonte A, Spaulding AC, Chhatwal J (2019) Prioritizing hepatitis C treatment in U.S. prisons. Oper. Res. 67(3):853–873.Link, Google Scholar
• Bellman R, Glicksberg I, Gross O (1955) On the optimal inventory equation. Management Sci. 2(1):83–104.Link, Google Scholar
• Boloori A, Saghafian S, Chakkera HA, Cook CB (2020) Data-driven management of post-transplant medications: An ambiguous partially observable Markov decision process approach. Manufacturing Service Oper. Management 22(5):1066–1087.Link, Google Scholar
• Bonifonte A, Ayer T, Haaland B (2022) An analytics approach to guide randomized controlled trials in hypertension management. Management Sci. 68(9):6634–6647.Link, Google Scholar
• Brønnnum-Hansen H, Jørgensen T, Davidsen M, Madsen M, Osler M, Gerdes LU, Schroll M (2001) Survival and cause of death after myocardial infarction: The Danish MONICA study. J. Clinical Epidemiology 54(12):1244–1250.Crossref, Google Scholar
• Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C (1994) Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 25(2):333–337.Crossref, Google Scholar
• Capan M, Khojandi A, Denton BT, Williams KD, Ayer T, Chhatwal J, Kurt M, et al. (2017) From data to improved decisions: Operations research in healthcare delivery. Medical Decision Making 37(8):849–859.Crossref, Google Scholar
• Cevik M, Ayer T, Alagoz O, Sprague BL (2018) Analysis of mammography screening policies under resource constraints. Production Oper. Management 27(5):949–972.Crossref, Google Scholar
• Chen Q, Ayer T, Chhatwal J (2018) Optimal M-switch surveillance policies for liver cancer in a hepatitis C-infected population. Oper. Res. 66(3):673–696.Link, Google Scholar
• Cohen JB, Townsend RR (2018) The ACC/AHA 2017 hypertension guidelines: Both too much and not enough of a good thing? Ann. Internal Medicine 168(4):287–288.Crossref, Google Scholar
• Denton BT, Alagoz O, Holder A, Lee EK (2011) Medical decision making: Open research challenges. IIE Trans. Healthcare Systems Engrg. 1(3):161–167.Crossref, Google Scholar
• Denton BT, Kurt M, Shah ND, Bryant SC, Smith SA (2009) Optimizing the start time of statin therapy for patients with diabetes. Medical Decision Making 29(3):351–367.Crossref, Google Scholar
• Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’agostino RB, Gibbons R, Greenland P, et al. (2014) 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J. Amer. College Cardiology 63(25 part B):2935–2959.Crossref, Google Scholar
• Grand-Clément J, Chan C, Goyal V, Chuang E (2021) Interpretable machine learning for resource allocation with application to ventilator triage. Preprint, submitted October 21, https://arxiv.org/abs/2110.10994.Google Scholar
• Hicklin K, Ivy JS, Payton FC, Viswanathan M, Myerse E (2018) Exploring the value of waiting during labor. Service Sci. 10(3):334–353.Link, Google Scholar
• Ioannidis JP (2018) Diagnosis and treatment of hypertension in the 2017 ACC/AHA guidelines and in the real world. JAMA 319(2):115–116.Crossref, Google Scholar
• Kochanek KD, Murphy SL, Xu J, Arias E (2019) Deaths: Final data for 2017. National Vital Statist. Rep. 68(9):1–18.Google Scholar
• Kohli-Lynch CN, Bellows BK, Thanassoulis G, Zhang Y, Pletcher MJ, Vittinghoff E, Pencina MJ, Kazi D, Sniderman AD, Moran AE (2019) Cost-effectiveness of low-density lipoprotein cholesterol level—Guided statin treatment in patients with borderline cardiovascular risk. JAMA Cardiology 4(10):969–977.Crossref, Google Scholar
• Kurt M, Denton BT, Schaefer AJ, Shah ND, Smith SA (2011) The structure of optimal statin initiation policies for patients with type 2 diabetes. IIE Trans. Healthcare Systems Engrg. 1(July):49–65.Crossref, Google Scholar
• Lakkaraju H, Rudin C (2017) Learning cost-effective and interpretable treatment regimes. Singh A, Zhu Jerry, eds. Proc. 20th Internat. Conf. Artificial Intelligence Statist. AISTATS 2017, vol. 54 (PMLR), 166–175.Google Scholar
• Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665.Crossref, Google Scholar
• Law MR, Wald NJ, Morris JK, Jordan RE (2003) Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials. BMJ 326(7404):1427.Crossref, Google Scholar
• Lee E, Lavieri MS, Volk M (2018) Optimal screening for hepatocellular carcinoma: A restless bandit model. Manufacturing Service Oper. Management 21(1):198–212.Link, Google Scholar
• Littman ML (1994) Memoryless policies: Theoretical limitations and practical results. From Animals Animats 3 Proc. Third Internat. Conf. Simulation Adaptive Behav., vol. 3 (MIT Press, Cambridge, MA), 238.Google Scholar
• Lovejoy WS (1987) Some monotonicity results for partially observed Markov decision processes. Oper. Res. 35(5):736–743.Link, Google Scholar
• Marrero WJ, Lavieri MS, Sussman JB (2021) Optimal cholesterol treatment plans and genetic testing strategies for cardiovascular diseases. Health Care Management Sci. 24(1):1–25.Crossref, Google Scholar
• Mason JE, Denton BT, Shah ND, Smith SA (2014) Optimizing the simultaneous management of blood pressure and cholesterol for type 2 diabetes patients. Eur. J. Oper. Res. 233(3):727–738.Crossref, Google Scholar
• Meraklı M, Küçükyavuz S (2020) Risk aversion to parameter uncertainty in Markov decision processes with an application to slow-onset disaster relief. IISE Trans. 52(8):811–831.Crossref, Google Scholar
• Neumann P, Sanders G, Russell L, Siegel J (2016) Cost-Effectiveness in Health and Medicine (Oxford University Press, Oxford, UK).Crossref, Google Scholar
• Pandya A, Sy S, Cho S, Weinstein MC, Gaziano TA (2015) Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease. JAMA 314(2):142–150.Crossref, Google Scholar
• Petrik M, Luss R (2016) Interpretable policies for dynamic product recommendations. Ihler A, Janzing D, eds. 32nd Conf. Uncertainty Artificial Intelligence 2016 UAI 2016 (AUAI Press), 607–616.Google Scholar
• Puterman ML (2014) Markov Decision Processes: Discrete Stochastic Dynamic Programming (John Wiley & Sons, New York).Google Scholar
• Rao A, Shi Z, Ray KN, Mehrotra A, Ganguli I (2019) National trends in primary care visit use and practice capabilities, 2008–2015. Ann. Family Medicine 17(6):538–544.Crossref, Google Scholar
• Rudin C, Chen C, Chen Z, Huang H, Semenova L, Zhong C (2022) Interpretable machine learning: Fundamental principles and 10 grand challenges. Statist. Surveys 16:1–85.Crossref, Google Scholar
• Saville CE, Smith HK, Bijak K (2019) Operational research techniques applied throughout cancer care services: A review. Health Systems (Basingstoke) 8(1):52–73.Crossref, Google Scholar
• Schäl M (1976) On the optimality of (s, S)-policies in dynamic inventory models with finite horizon. SIAM J. Appl. Math. 30(3):528–537.Crossref, Google Scholar
• Schell GJ, Marrero WJ, Lavieri MS, Sussman JB, Hayward RA (2016) Data-driven Markov decision process approximations for personalized hypertension treatment planning. MDM Policy Practice 1(1):2381468316674214.Crossref, Google Scholar
• Serfozo RF (1976) Monotone optimal policies for Markov decision processes. Wets RJB, eds. Stochastic Systems: Modeling, Identification and Optimization, II, Mathematical Programming Studies, vol. 6 (Springer, Berlin), 202–215.Crossref, Google Scholar
• Serin Y, Kulkarni VG (1995) Implementable policies: Discounted cost case. Stewart WJ, eds. Computations with Markov Chains (Springer, Boston), 283–306.Crossref, Google Scholar
• Sethi T, Kalia A, Sharma A, Nagori A (2020) Interpretable Artificial Intelligence: Closing the Adoption Gap in Healthcare (Elsevier, Amsterdam).Google Scholar
• Skandari MR, Shechter SM (2021) Patient-type Bayes-adaptive treatment plans. Oper. Res. 69(2):574–598.Link, Google Scholar
• Solberg LI, Miller WL (2018) The new hypertension guideline: Logical but unwise. Family Practice 35(5):528–530.Crossref, Google Scholar
• Steimle LN, Kaufman DL, Denton BT (2021) Multi-model Markov decision processes. IISE Trans. 53(10):1124–1139.Google Scholar
• Suen S-C, Brandeau ML, Goldhaber-Fiebert JD (2018) Optimal timing of drug sensitivity testing for patients on first-line tuberculosis treatment. Health Care Management Sci. 21(4):632–646.Crossref, Google Scholar
• Sussman J, Vijan S, Hayward R (2013) Using benefit-based tailored treatment to improve the use of antihypertensive medications. Circulation 128(21):2309–2317.Crossref, Google Scholar
• Tjoa E, Guan C (2021) A survey on explainable artificial intelligence (XAI): Toward medical XAI. IEEE Trans. Neural Networks Learn. Systems 32(11):4793–4813.Crossref, Google Scholar
• Tunç S, Alagoz O, Burnside ES (2022) A new perspective on breast cancer diagnostic guidelines to reduce overdiagnosis. Production Oper. Management 31(5):2361–2378.Crossref, Google Scholar
• Van Der Wardt V, Harrison JK, Welsh T, Conroy S, Gladman J (2017) Withdrawal of antihypertensive medication: A systematic review. J. Hypertension 35(9):1742–1749.Crossref, Google Scholar
• Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, et al. (2020) Heart disease and stroke statistics—2020 update: A report from the American Heart Association. Circulation 141(9):e139–e596.Crossref, Google Scholar
• Vlassis N, Littman ML, Barber D (2012) On the computational complexity of stochastic controller optimization in POMDPs. ACM Trans. Comput. Theory 4(4):12.Crossref, Google Scholar
• Wang F, Kaushal R, Khullar D (2020) Should health care demand interpretable artificial intelligence or accept “black box” medicine? Ann. Internal Medicine 172(1):59–60.Crossref, Google Scholar
• Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, et al. (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Amer. College Cardiology 71(19):e127–e248.Crossref, Google Scholar